SYNAPSE (www.SYNAPSE-managers.com) is a company specialised in the high-quality management of complex research and development projects in the biomedical sector, partnering with public and private national and international organisations (pharmaceutical and biotechnology companies, research institutes, academia, hospitals, etc.). SYNAPSE has a long-standing track record on large highly innovative and multidisciplinary projects (open innovation, public private partnerships) with broad expertise in projects funded by the European Commission and the Innovative Medicines Initiative JU.
SYNAPSE leverages the expertise of highly skilled, experienced project management professionals with a track record of over 20 years in international collaboration projects, with special attention to EC-funded projects since Framework Programme 3, including a variety of programmes and funding schemes. The company manages 13 IMI projects, having acted as Coordinators of the Programme Management Office of the IMI JU funding for EMIF, a large-scale IMI project (56 M€) and being Project Manager of the EPAD Project (64 M€), the eTRANSAFE project (40 M€), PARADIGM (9 M€) and the EHDEN project (28 M€). The expertise of the team covers: project management, financial and legal assessment, exploitation and IPR management, knowledge management, validation and assessment, business planning, training, dissemination and communication strategies design and implementation.